Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Francisco Villarreal
University of California, San Diego, Department: Internal Medicine/medicine
Should you be removed from our database? Contact us at [email protected]. Read more below.
Cardero Therapeutics
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Dr. Villarreal is a company co-founder, holds a (b)(4) equity interest in the company. The company develops a class of compounds which target mitochodrial biogenesis and treat cardiovascular diseases and metabolic diseases. This project is to determine the role of mitochondria in allowing for muscle growth to occur in the setting of type 2 diabetes. A class of compounds provided by the company that stimulate mitochondria formation will be used.
Epicatechin and derivatives to preserve muscle structure function in diabetes
The major goal of this proposal is to determine the role that mitochondria play in allowing for muscle growth to occur in the setting of type 2 diabetes. We propose to test this hypothesis by using a class of novel and effective compounds that stimulate mitochondria formation and thus, likely muscle growth. Thus, the science advanced by this proposal may allow us to develop safe and effective new therapies to treat diabetes.
Filed on October 24, 2014.
Tell us what you know about Francisco Villarreal's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Francisco Villarreal filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Francisco Villarreal | University of California, San Diego | Conflict of Interest | Cardero Therapeutics | $500,000 - $549,999 |
| Francisco Villarreal | University of California, San Diego | Conflict of Interest | Cardero Therapeutics | $500,000 - $549,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.